On Tuesday, Eldorado Gold Corp (USA) (NYSE:EGO)’s shares inclined 1.68% to $4.85.
Eldorado Gold Corp (USA) (EGO) declare the completion of the Feasibility Study (“FS” or the “Study”) with its’ partner, Deva Gold S.A., for the 80.5%-owned Certej project (“Certej” or the “Project”) in Romania. The Study was led by an internal team with technical support offered by various Canadian and Romanian consultants. The Certej project is located in the southern part of the Apuseni Mountains in central Romania, about 12 kilometres north-east of the regional town of Deva in Hunedoara County.
The Study’s highlights comprise:
- Generation of a post-tax internal rate of return (IRR) of 13% and a net present value (“NPV”) at a 5% discount rate of $229 million.
- An open pit strip ratio of 2.96:1, mining a total of 44 million tonnes (Mt) of ore over the life of mine.
- Estimated cash operating costs of $568/oz and all-in sustaining costs of $745/oz.
- Initial capital estimate of $449 million and sustaining capital estimate of $203 million (counting closure).
- Processing rate of ~8,000 tonnes per day (“tpd”) would produce an average of 140,000 oz Au and 830,000 oz Ag per year.
- Confirmation of Pressure Oxidation (POX) for mineral processing; regarded as Best Accessible Technology.
- Recoveries of 87.4% and 80% for gold and silver respectively.
Eldorado Gold Corporation, together with its auxiliaries, engages in the exploration, discovery, development, production, and reclamation of gold properties, primarily in Brazil, China, Greece, Turkey, and Romania. It also explores for iron, silver, lead, zinc, and copper ores.
Royal Dutch Shell plc (ADR) (NYSE:RDS.A)’s shares gained 1.13% to $59.58.
In conformity with the Disclosure and Transparency Rules, we hereby notify the market of the following:
Royal Dutch Shell plc’s (RDS-A) capital comprises of 3,894,584,881 A shares and 2,440,410,614 B shares, each with equal voting rights. Royal Dutch Shell plc holds no ordinary shares in Treasury.
The total number of A shares and B shares in issue is 6,334,995,495 and this figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Royal Dutch Shell plc under the FSA’s Disclosure and Transparency Rules.
Royal Dutch Shell plc operates as an independent oil and gas company worldwide. It operates through Upstream and Downstream segments. The company explores for and extracts crude oil, natural gas, and natural gas liquids. It also converts natural gas to liquids to provide fuels and other products; markets and trades natural gas; extracts bitumen from mined oil sands and converts it to synthetic crude oil; and generates electricity from wind energy. In addition, the company engages in manufacturing, supplying, and shipping crude oil; selling fuels, lubricants, bitumen, and liquefied petroleum gas (LPG) for home, transport, and industrial use; converting crude oil into a range of refined products, counting gasoline, diesel, heating oil, aviation fuel, marine fuel, lubricants, bitumen, sulphur, and LPG; producing and marketing petrochemicals, such as the raw materials for plastics, coatings, and detergents for industrial customers; and alternative energy business.
At the end of Tuesday’s trade, Amarin Corporation plc (ADR) (NASDAQ:AMRN)‘s shares dipped -0.65% to $2.30.
Amarin Corporation plc (ADR) (AMRN) declared financial results for the quarter ended March 31, 2015, and offered an update on company operations.
Key Amarin achievements since December 31, 2014 comprise:
- R&D progress: REDUCE-IT cardiovascular outcomes study, designed to provide data to support a significantly expanded label for Vascepa, continued on plan for a protocol pre-specified interim efficacy look by the independent Data Monitoring Committee (DMC) in 2016 and, if not stopped early, for completion in 2017 and presentation/publication of results in 2018;
- Revenue growth: Recognized $15.6 million in net product revenue from Vascepa sales in Q1 2015 contrast to $11.0 million in Q1 2014, an enhance of 42%;
- Prescription growth: Raised normalized prescriptions, based upon data from Symphony Health Solutions, by 66% in Q1 2015 contrast to Q1 2014;
Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States.
Wendys Co (NASDAQ:WEN), ended its Tuesday’s trading session with -0.18% loss, and closed at $11.10.
Wendys Co (WEN) declared that one of its indirect, special purpose auxiliaries (the “Master Issuer”) has accomplished the sale of $875 million of its Series 2015-1 3.371% Fixed Rate Senior Secured Notes, Class A-2-I (the “Class A-2-I Notes”), $900 million of its Series 2015-1 4.080% Fixed Rate Senior Secured Notes, Class A-2-II (the “Class A-2-II Notes”), and $500 million of its Series 2015-1 4.497% Fixed Rate Senior Secured Notes, Class A-2-III (the “Class A-2-III Notes” and, together with the Class A-2-I Notes and the Class A-2-II Notes, the “Notes”). Interest payments on the Notes are payable on a quarterly basis. The legal final maturity date of the Notes is in June of 2045, but, unless earlier prepaid to the extent permitted under the indenture that governs the Notes, the anticipated repayment dates of the Class A-2-I Notes, the Class A-2-II Notes and the Class A-2-III Notes will be 4.25, 7 and 10 years, respectively. The Notes were issued by the Master Issuer in a privately placed securitization transaction.
The Master Issuer also reached a purchase agreement for the issuance of up to $150 million Series 2015-1 Class A-1 Notes, which will allow the Master Issuer to borrow amounts from time to time on a revolving basis.
The net proceeds from the sale of the Notes will be used for repayment of existing senior secured indebtedness, transaction costs associated with the refinancing, and general corporate purposes, counting the return of cash to shareholders.
The Wendy’s Company, through its auxiliaries, owns and franchises Wendy’s restaurant system. The company is involved in operating, developing, and franchising a system of quick-service restaurants. As of May 26, 2015, its restaurant system comprised of about 6,500 franchised and company-operated restaurants worldwide. The company was formerly known as Wendy’s/Arby’s Group, Inc. and changed its name to The Wendy’s Company in July 2011.
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.